News

AstraZeneca begins coronavirus trial

AstraZeneca has begun a phase-one trial of an antibody treatment to “prevent or treat” coronavirus, the British pharma giant confirmed in a London stock exchange statement on 25 August.

The trial will include up to 48 healthy participants in the UK, aged between 18 and 55 years.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire